Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segmented Information (Tables)

Segmented Information (Tables)

6 Months Ended

Feb. 28, 2015

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Alternative	Marijuana
	Oil and Gas	Health Products	business	Corporation	Total
	$	$	$	$	$
Revenue	48,918	2,883	-		51,801
Operation expenses	-	90,074	31,126	736,312	857,512
Total assets		121,556	52,662	1,036,282	1,210,500

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details